Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Insights into the Control of Cellular Protein Production

11.01.2010
Researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained new insights into the control of cellular protein production.

Experimental analysis of genetically modified mice revealed that an evolutionary conserved regulatory mechanism of protein production plays an important role in highly developed mammals.

The mouse-model findings of Dr. Klaus Wethmar, Professor Achim Leutz and colleagues could contribute to the development of new therapies and drugs to combat diseases such as cancer. (Genes & Development, doi: 10.1101/gad.557910).*

Proteins are the building blocks of every living cell. The blueprints of the proteins are encoded in the DNA of genes. These blueprints are first transcribed into messenger RNA (mRNA), which then serve as a template for protein production. Some mRNAs contain short upstream open reading frames (uORFs), which control protein production depending on the respective cell physiology. Such regulatory uORFs occur in all organisms from yeast to humans. They are predominantly prevalent in the mRNAs of key regulatory proteins involved in cell proliferation and differentiation as well as cell metabolism and cellular stress management.

In their studies on a mouse model, MDC researchers led by Professor Leutz succeeded for the first time in detecting and measuring the physiological relevance of an uORF conserved in all vertebrates including humans. They discovered that mice deficient in the uORF of an important regulatory protein showed disturbed liver regeneration and impaired bone growth. Based on these findings, together with the widespread prevalence of uORFs in numerous other mRNAs, the MDC researchers suggest that evolutionary conserved uORFs may have comprehensive regulatory functions in the living organism.

The MDC scientists suspect that regulation of protein production by uORFs is associated with many diseases, in particular cancer diseases, since for example the transcripts of growth factors or oncogenes often contain uORFs. "Currently, no drugs exist which specifically target the control of protein production by uORFs," Professor Leutz explained. "However, since the regulatory function of uORFs is highly relevant, it would be reasonable to screen for drugs which can influence the function of uORFs."

*C/EBPbeta?uORF mice - a genetic model for uORF-mediated translational control in mammals
Klaus Wethmar1,2, Valérie Bégay1,3, Jeske J. Smink1,3, Katrin Zaragoza1,3, Volker Wiesenthal1,4, Bernd Dörken2, Cornelis F. Calkhoven5 and Achim Leutz1,6,7
1) Max Delbrück Center for Molecular Medicine, Robert Rössle Str. 10, D-13092 Berlin, Germany.
2) Charité, Campus Virchow Klinikum, University Medicine Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.
3) These authors contributed equally to this study and are listed in alphabetical order.
4) Current address: Deutsches Zentrum für Luft- und Raumfahrt e.V., Heinrich-Konen-Str. 1, 53227 Bonn, Germany.
5) Leibniz Institute for Age Research - Fritz Lipmann Institute, Beutenbergstr. 11, D-07745 Jena, Germany.
6) Department of Biology, Humboldt-University, Invalidenstr. 43, D-10115 Berlin, Germany.

7) Corresponding author

Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de

Barbara Bachtler | Max-Delbrück-Centrum
Further information:
http://www.mdc-berlin.de/

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>